IN CONVERSATION: DR. JEFF STROVEL, CEO of VERALOX THERAPEUTICS

Published on :

IN CONVERSATION: DR. JEFF STROVEL, CEO of VERALOX THERAPEUTICS Veralox Therapeutics is a startup currently headquartered at the Frederick Innovation  Technology Center, Inc. (FITCI) in Frederick, Maryland. As a small molecule therapeutics company focused on developing medicines targeting the arachidonic acid pathway, they have two drug products in development for the treatment of a rare [….]

In Conversation: Sean Kirk, Emergent BioSolutions

Published on :

In Conversation: Sean Kirk, Emergent BioSolutions Following up on the recent article Two Maryland Biotechs Partner to Bring Coronavirus/COVID-19 Vaccine Candidate into Clinical Trials, BioBuzz had the opportunity to speak with Emergent BioSolutions Executive Vice President, Manufacturing and Technical Operations, Sean Kirk. Let’s start by having you provide a brief background on your role at [….]

WIB-Capital Region: Member Spotlight with Julie (Wu) Rosen, Ph.D.

Published on :

WIB-Capital Region: Member Spotlight with Julie (Wu) Rosen, Ph.D. Tuesday, February 11, 2020 Tell us about your background (both educational and professional). I am an Assistant Professor in the Department of Obstetrics, Gynecology & Reproductive Sciences at the University of Maryland School of Medicine (UMSOM), and I serve as one of two Executive Directors for [….]

In Conversation: Dr. Harsha K. Rajasimha, IndoUSrare

Published on :

In Conversation: Dr. Harsha K. Rajasimha, IndoUSrare BioBuzz recently sat down for a conversation with Dr. Harsha K. Rajasimha, a leading rare disease advocate, the founder of the non-profit, IndoUSrare, and the CEO of Jeeva Informatics, a leading AI and digital health company focused on decentralized clinical trials.  February is Rare Disease Month. What does [….]